Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,517.90
(
0.66%
)
News Focus
News Focus
Post# of 105
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

braden

Send PM Follow Ignore
Followers 22
Posts 6915
Boards Moderated 0
Alias Born 07/31/2006

braden

Re: None

Friday, 08/05/2016 3:45:51 PM

Friday, August 05, 2016 3:45:51 PM

Post# of 105
West Pharmaceutical Services Inc. (NYSE:WST) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday. The brokerage presently has a $91.00 target price on the stock. Zacks Investment Research’s target price would suggest a potential upside of 11.66% from the company’s current price

Get your swing trade ideas at http://investorshub.advfn.com/boards/board.aspx?board_id=11403

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent WST News
More WST News